Thyroid transcription factor‐1 and epithelial membrane antigen expression in four cases of subependymal giant cell astrocytoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|66|7|1035-1036

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.66, Iss.7, 2015-06, pp. : 1035-1036

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neonatal Subependymal Giant Cell Astrocytoma

By  

Pediatric Neurosurgery, Vol. 36, Iss. 5, 2002-05 ,pp. : 271-274

Karger

Access to resources Recommend Favorite

Everolimus for subependymal giant cell astrocytoma: 5‐year final analysis

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 6, 2015-12 ,pp. : 929-938

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose‐level response rates of mtor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 10, 2015-10 ,pp. : 1754-1760

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological and molecular implications of aberrant thyroid transcription factor‐1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones

By  

HISTOPATHOLOGY, Vol. 72, Iss. 3, 2018-02 ,pp. : 423-432

John Wiley & Sons Inc

Access to resources Recommend Favorite

Giant Basal Cell Carcinomas: Report of Four Cases and Considerations

By  

THE JOURNAL OF DERMATOLOGY, Vol. 24, Iss. 5, 1997-05 ,pp. : 317-321

John Wiley & Sons Inc

Access to resources Recommend Favorite